Both stocks run through our valuation models. Here is how Neurizer (NRZ) and Corteva (CTVA) compare, as of Aug 18, 2026.
As of Aug 18, 2026, Fair Value Calculator sees Neurizer as the less overvalued of the two: Neurizer trades at A$0.00 versus a fair value of A$0.00 (-20%), while Corteva trades at $76.01 versus $27.81 (-63%).
Neurizer
NRZ.AU · AUD · Energy
-20%
upside to fair value
overvalued
PriceA$0.00
Fair ValueA$0.00
Quality20/100
Corteva
CTVA · USD · Materials
-63%
upside to fair value
overvalued
Price$76.01
Fair Value$27.81
Quality71/100
Get comparisons like this free by email every month: the most undervalued quality stocks.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
NeurizerCorteva
Valuation
—P/E (TTM)46.3×
—P/S (TTM)3.20×
—P/B2.37×
—EV/EBITDA13.2×
—PEG1.44×
8.7%Dividend yield0.9%
—Dividend per share$0.72
Profitability
0%Net margin7%
0%Operating margin24%
-11%Return on equity5%
-2%Return on assets4%
Growth
0%Revenue growth (YoY)11%
-34.5%Avg. growth/yr (3Y)-0.1%
-50.3%Avg. growth/yr (5Y)4.1%
Balance & size
0.01×Debt / equity0.07×
$2MMarket cap$57B
weakGrowth qualityhealthy
Corteva leads: 2 to 7 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Neurizerof which business quality 24 · market factors 56Cortevaof which business quality 69 · market factors 58
ProfitabilityMargins and returns on capital today
1
30
Quality GrowthAre margins and returns improving?
90
48
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
13
97
Low VolatilityCalm price path (market factor)
100
84
MomentumPrice trend over the last 3–12 months (market factor)
40
45
52W MomentumDistance to the 52-week high (market factor)
33
49
Net IssuanceBuybacks instead of dilution
0
100
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Neurizer
Asset-BasedA$0.01
0 of 1 models see the stock below the current price.
Corteva
DCF Models$50.58
Earnings-Based$30.99
Dividend Discount$9.27
Multiples$35.54
Asset-Based$24.19
Growth DCF$57.96
Economic Profit$34.06
Growth Earnings$21.85
24 of 24 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Corteva
Bear $20.86Fair Value $27.81Bull $34.76
$76.01 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Neurizer · Energy
Quality score20 · bottom 25%
Fair value upside-20% · above median
Corteva · Materials
Quality score71 · Top 25%
Fair value upside-63% · bottom 25%
Bottom line
As of Aug 18, 2026, Fair Value Calculator sees Neurizer as the less overvalued of the two: Neurizer trades at A$0.00 versus a fair value of A$0.00 (-20%), while Corteva trades at $76.01 versus $27.81 (-63%).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
